Episiotomy Closure: indicated episiotomy with Novosyn® Quick after spontaneous vaginal delivery
Study summary
Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick
Exclusion Criteria:
* No exclusion criteria have been set
Primary outcome measure(s)
Wound dehiscence rate — up to 1 month postpartum A dehiscence of the wound which needs surgical treatment with re-closure.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.